Francois Haguinet

GSK

Presentation(s):

• OP-26A - Evaluation of the Potential Confounding Effect of Shingles on the Risk of Guillain-barré Syndrome After Vaccination with the Recombinant Zoster Vaccine

  Monday, August 23, 2021
  1:45 PM – 3:30 PM US Eastern Time